Skip to main content
. 2015 Apr 29;36(7):739–747. doi: 10.1093/carcin/bgv059

Figure 1.

Figure 1.

Kaplan–Meier survival curves in serous ovarian carcinoma patients with low and high levels of ADAM12. (A) Survival curves in HGSOC patients with low (<1ng/ml) and high (>1ng/ml) preoperative serum levels of ADAM12. (B) Survival curves in serous ovarian cancer patients with low and high expression levels of ADAM12 mRNA (202952_s_at) from 13 combined public ovarian cancer data sets in the Kaplan–Meier plotter database.